CA Tumor Markers Testing Market Pegged for Robust Expansion During 2016 - 2023
Tumor markers are biological substances found in the body tissues, blood and urine; that can be elevated when a person is suffering from cancer. Tumor markers are normally made of cancerous cells or by the body in response to cancer. Traditional tumor markers are proteins; however newer tumor markers are genetic substances. There are various types of cancer antigen (CA) tumor markers each indicative of a specific disease mechanism; and these tumors are used in oncology to help in the detection of cancer of a particular organ or site. An elevated level of a CA tumor marker can signify various forms of cancer such as breast cancer, colorectal cancer and ovarian cancer. Currently, the CA tumor marker testing market is a lucrative thanks to the high numbers of patients opting for such testing and the increasing base of cancer patients, which makes this industry not only highly profitable but also attractive to investors.
Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11600
Some of the technologies used for the detection of CA tumor markers are as follows:
Enzyme Immunoassays (EIA)
Nucleic acid sequence based amplification (NASBA)
Some of the types of cancer antigen marker usually used for cancer tumor testing are as follows:
Cancer Antigen 125 (CA 125), used for detecting epithelial ovarian cancer
Cancer Antigen 27-29 (CA 27-29), used for detecting breast cancer
Cancer Antigen 19-9 (CA 19-9), used for detecting colorectal cancer
Cancer Antigen 15-3 (CA 15-3), used for detecting breast cancer
CA Tumor Markers Testing Market: Regional Overview
From the geographical perspective, North America stands as the largest market for CA tumor markers testing owing to the large base of cancer patients. According to the American Cancer Society, approximately 1,660, 290 new cases of cancer were diagnosed in 2013. Another report published by the WHO, it was estimated that globally 14.1 million new cases of cancer were diagnosed and almost 8.2 million deaths related to cancer occurred in 2012.
Request For Discount On This Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=11600
However, other regional markets such as Southeast Asia, the Middle East, and Latin America are projected to be the potential markets in the near future. This can be ascribed to the increasing levels of disposable income among the population and the high rate of adoption of advanced cancer screening tools. It is expected that these emerging regions will be high-potential markets in the near future.
CA Tumor Markers Testing Market: Drivers
The overall CA tumor marker testing market is witnessing a remarkable growth owing to the increasing rate of incidence of cancer and other non-communicable disorders. Moreover, increasing geriatric population will further fuel the growing demand for tumor assays and novel cancer therapeutics globally. Moreover, trends show that the global CA tumor marker testing market could potentially be a lucrative field showing continued expansion owing to the spiraling adoption rate of diagnostic services and technologies that are more advanced than the previous ones.
View Report: https://www.transparencymarketresearch.com/ca-tumor-markers-testing-market.html
With technological breakthroughs on the cards, projections show that this market will generate abundant opportunities for detecting targeted tumors, monitoring cellular response and for determining genetic predisposition. Furthermore, increased focus on retaining superior quality of life is some of the factors contributing in the growth of this market. However, a rise in the overall healthcare spending, rigid and, in some cases, unfavorable, reimbursement policies, and the high cost of developing new technologies are some of the factors that might act in the opposite direction of the growth of the CA tumor marker testing market.
CA Tumor Markers Testing Market: Competitive Dynamics
The global CA tumor markers testing market is observed as being a highly fragmented one because of the active participation of many players both established and emerging. The major players involved with the CA tumor markers testing market are Abbott Laboratories, Becton, Dickinson and Company, Applied Genetic Technologies Corporation, bioMérieux SA, Cepheid, Correlogic Systems, Inc., Myriad Genetics, Panacea Pharmaceuticals, Qiagen, Radient Pharmaceuticals, Siemens Healthcare, Targeted Diagnostics & Therapeutics and Thermo Fisher Scientific.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CA Tumor Markers Testing Market Pegged for Robust Expansion During 2016 - 2023 here
News-ID: 1014871 • Views: 186
More Releases from Transparency Market Research
Voltage Detectors Market – Evolving Technology Trends and Industry SWOT Analys …
The global voltage detectors market includes large number of players. Some of the key players are Texas Instruments, Toshiba, ROHM Semiconductor Sharp Microelectronics, Analog Devices Inc., STMicroelectronics, ON Semiconductor, Torex Semiconductor, Taiwan Semiconductor and Seiko Instruments. Browse Our Report @ https://www.transparencymarketresearch.com/voltage-detectors-market.html Voltage Detector is a testing equipment generally used to determine the existence or absence of an electrical charge in an object. It is highly suggested for conditions where power issues exist.
Switched Capacitor Filters Market : Key Segments, Maket Insights, Regional Outlo …
Major players in the global switched capacitor filters market are Texas Instruments Incorporated, Analog Devices, Inc., Maxim Integrated, Inc., Siemens AG, Eaton Corporation, and among others. Browse Our Report @ https://www.transparencymarketresearch.com/switched-capacitor-filters-market.html A switched capacitor filter is an active filter based on the consideration that a switching of capacitors between two circuit nodes at an adequately high rate that is equivalent to a resistor connecting these two nodes. The switched capacitor filters are
Current Calibrator Market : Recent Industry Developments And Growth Strategies A …
Key players operating in the global current calibrator market include Valhalla Scientific, Rotek Inc., Time Electronics, PCE Instruments, Martel Electronics, AOIP Instrumentation, Extech Instruments, Yogokawa Test & Measurement Corporation, Extech Instruments, REED Instruments, Fluke Corporation, and others. These players are actively focusing on organic and inorganic growth strategies in order to gain a competitive advantage in the market. Some of the important strategies adopted by the leading players in the
Damp Meter Market – Outlook by Responsible Drivers, Restraints, Demand
Key players operating in the global damp meter market include PCE Instrument, Delmhorst Instrument Co., GENERAL TOOLS & INSTRUMENTS LLC, FLIR Systems, Inc. designs, Panomex Inc., These players are actively focusing on organic and inorganic growth strategies in order to gain a competitive advantage in the market. Some of the important strategies adopted by the leading players in the global market are collaborations, partnerships, agreements, and new product launches. The
More Releases for Tumor
Rising Prevalence of brain Tumor Couple with Geriatric Populations supporting gr …
Albany, NY, 26th February : Recent research and the current scenario as well as future market potential of "Brain Tumor Therapeutics: Global Markets to 2023" globally. ResearchMOZ.us has published a fresh report to its vast repository titled “Global Brain Tumor Therapeutics Market - Segmented by Type of Cancer and Therapeutics - Growth, Trends and Forecasts 2018-2026” to its offerings. The report provides comprehensive analysis of the global tumor therapeutics market in the
Global Tumor Ablation Devices Market - Insights
Increasing prevalence of various cancer globally rising the demand of treatment through ablation procedure due to its lesser/minimal side effect rates over other procedures intended to boost the tumor ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the world, with approximately 14 million new cases reported worldwide in 2012. Click To Continue Reading: https://www.coherentmarketinsights.com/market-insight/tumor-ablation-devices-market-1270 Tumor Ablation devices market
Global Tumor Ablation Devices Market - Insights
Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators,
Tumor Ablation Market: Industry Evolution/Development
A recent study by Transparency Market Research (TMR) has detected that the competition in the global tumor ablation market is intense, in a fragmented scenario with the presence of a number of participants. That being said, there are plenty of growth opportunities too in the market for tumor ablation, which will continue to attract pharmaceutical companies and further intensify the competition. The TMR report projects the global tumor ablation market
Tumor Necrosis Factor Receptor
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Tumor Necrosis Factor - Pipeline Review, H2 2017” Tumor Necrosis Factor Overview Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed
Personalised tumor vaccines keep cancer in check
Throughout the last decade, novel cancer therapeutics has seen tremendous developments, through targeting tumor cell-intrinsic pathways, as well as targeting tumor cell-extrinsic factors such as growth factors. Notable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further demonstrates the critical role of T-cells in cancer control and rejection. However, many patients still do not respond to checkpoint inhibitor therapies. This creates the need for